ConceptioArchiveHAL (France)
HAL (France)open access

Somapacitan in Children Born SGA: 52-Week Efficacy, Safety, and IGF-I Response Results From the Phase 2 REAL5 Study

Anders Juul et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
2, 1, 0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 250363
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.